Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Health Econ Rev. 2020 Apr 17;10(1):8. doi: 10.1186/s13561-020-00265-0.

¹ Grifols Shared Services North America (SSNA), Inc, Research Triangle Park, Raleigh, NC, USA.
² Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
³ Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.
⁴ European Foundation of Chronic Liver Failure (EF-Clif), Barcelona, Spain.
⁵ Department of Internal Medicine I, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
⁶ Xcenda L.L.C, Palm Harbor, FL, USA. rashad.carlton@xcenda.com.
⁷ Senior Director Medical Affairs, Retrophin, San Diego, CA, USA.

Abstract

Following publication of the original article [1], the authors reported that one of the numbers within Fig. 6 contains a mistake.